Literature DB >> 24715630

Retrospective analysis of 15 cases of Penicilliosis marneffei in a southern China hospital.

Fengli Zhou1, Xiaogang Bi, Xiaoling Zou, Zhiyang Xu, Tiantuo Zhang.   

Abstract

We retrospectively analyzed the medical records and clinical characteristics of 15 patients diagnosed with Penicilliosis marneffei (PSM) between January 1, 1993, and December 31, 2012, at the Third Affiliated Hospital of Sun Yat-sen University. The most common symptoms of PSM were fever (14/15, 93 %), cough (13/15, 87 %), and sputum production (6/15, 40 %), weight loss (14/15, 60 %), lymph node enlargement (9/15, 60 %), hepatosplenomegaly (7/15, 47 %), anemia (7/15, 47 %), and hemoptysis (4/15, 26 %). The most common underlying diseases in patients diagnosed with PSM were AIDS (9/15, 60 %), post-organ transplantation (3/15, 20 %), rheumatic autoimmune disease (2/15, 13 %), and hematological malignancy (1/15, 7 %). All patients, except those with AIDS, were treated with immunosuppressant drugs. White blood cell counts were increased in 10/15 (67 %) patients, while hemoglobin concentrations were decreased in 8/15 (53 %) patients. The ratios of CD4(+)/total T lymphocytes and CD4(+)/CD8(+) T lymphocytes declined in all the 11 test cases. Nodular lesions or masses were the most common anomalies detected during computed tomography scans, but disseminated inflammation and interstitial changes were also seen. Clinical samples with positive culture results were obtained from sputum or secretions obtained by bronchoscopy, venous blood, percutaneous pulmonary puncture, bone marrow, or skin lesions. Between 1993 and 2003, only four cases of PSM, all connected with AIDS, were diagnosed, while 11 cases of PSM, with or without concurrent AIDS, were diagnosed between 2003 and 2012. Amphotericin B was used to control the disease in some cases. In conclusion, the occurrence of PSM, especially in patients without concurrent AIDS, has increased. The early culture of Penicillium marneffei from clinical samples is critical for correct diagnosis of PSM, and amphotericin B is recommended as the first choice for treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715630     DOI: 10.1007/s11046-014-9737-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   3.785


  26 in total

1.  Penicillium marneffei infection presenting as oral ulcerations in a patient infected with human immunodeficiency virus.

Authors:  A C Tong; M Wong ; N J Smith
Journal:  J Oral Maxillofac Surg       Date:  2001-08       Impact factor: 1.895

2.  [An analysis of opportunistic infection in 762 inpatients with human immunodeficiency virus infection in Guangdong areas].

Authors:  Li-fen Huang; Xiao-ping Tang; Wei-ping Cai; Xie-jie Chen; Chun-liang Lei; Ling-hua Li; Fu-chun Zhang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2010-08

3.  Interactions of Penicillium marneffei with human leukocytes in vitro.

Authors:  Y Rongrungruang; S M Levitz
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Prospective study of biomarkers of immune response in lung transplant recipients.

Authors:  D San Segundo; M Brunet; M A Ballesteros; O Millán; M Muro; M J Castro; E Miñambres; M López-Hoyos
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

Review 5.  Emerging systemic fungal infections.

Authors:  Ricardo Galimberti; Ana Clara Torre; María Carolina Baztán; Florencia Rodriguez-Chiappetta
Journal:  Clin Dermatol       Date:  2012 Nov-Dec       Impact factor: 3.541

Review 6.  Penicilliosis in lupus patients presenting with unresolved fever: a report of 2 cases and literature review.

Authors:  Y B Chong; L P Tan; S Robinson; S K Lim; K P Ng; T C Keng; A Kamarulzaman
Journal:  Trop Biomed       Date:  2012-06       Impact factor: 0.623

7.  Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome.

Authors:  M R Piehl; R L Kaplan; M H Haber
Journal:  Arch Pathol Lab Med       Date:  1988-12       Impact factor: 5.534

8.  Travel-related disseminated Penicillium marneffei infection in a renal transplant patient.

Authors:  J Hart; J R Dyer; B M Clark; D G McLellan; S Perera; P Ferrari
Journal:  Transpl Infect Dis       Date:  2011-12-20       Impact factor: 2.228

9.  Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.

Authors:  Thuy Le; Marcel Wolbers; Nguyen Huu Chi; Vo Minh Quang; Nguyen Tran Chinh; Nguyen Phu Huong Lan; Pham Si Lam; Michael J Kozal; Cecilia M Shikuma; Jeremy N Day; Jeremy Farrar
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

10.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

View more
  13 in total

1.  Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.

Authors:  Pingli Wang; Youfei Chen; Hao Xu; Liren Ding; Zuqun Wu; Zhijiang Xu; Kai Wang
Journal:  Mycopathologia       Date:  2017-03-27       Impact factor: 2.574

Review 2.  [Tropical and travel-related dermatomycoses : Part 2: cutaneous infections due to yeasts, moulds, and dimorphic fungi].

Authors:  P Nenoff; D Reinel; C Krüger; H Grob; P Mugisha; A Süß; P Mayser
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

Review 3.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

4.  Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?

Authors:  Chi-Ching Tsang; Susanna K P Lau; Patrick C Y Woo
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

5.  Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions.

Authors:  Ye Qiu; Jianquan Zhang; Guangnan Liu; Xiaoning Zhong; Jingmin Deng; Zhiyi He; Bai Jing
Journal:  BMC Infect Dis       Date:  2015-02-06       Impact factor: 3.090

6.  T. marneffei infection complications in an HIV-negative patient with pre-existing pulmonary sarcoidosis: a rare case report.

Authors:  Xiaoming Yu; Keji Miao; Changsheng Zhou; Yuelin Cai; Xiaoying Huang; Yanfan Chen; Mayun Chen; Hui Cai; Lin Zhang
Journal:  BMC Infect Dis       Date:  2018-08-10       Impact factor: 3.090

7.  Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study.

Authors:  Junjun Jiang; Fengxiang Qin; Sirun Meng; Eric J Nehl; Jinping Huang; Yanfen Liu; Jun Zou; Wenyi Dong; Jiegang Huang; Hui Chen; Ning Zang; Bingyu Liang; Chuanyi Ning; Yanyan Liao; Chaolian Luo; Huifang Liu; Xin Liu; Jian Wang; Oulu Zhou; Thuy Le; Li Ye; Fengyao Wu; Hao Liang
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

8.  Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient.

Authors:  Jiejun Shi; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2021-03-29

Review 9.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

10.  Non-HIV talaromycosis: Radiological and clinical analysis.

Authors:  Xinchun Li; Wenqing Hu; Qi Wan; Qiang Lei; Chongpeng Sun; Zhongjun Hou; Nitesh Shrestha
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.